Edition:
United States

Moleculin Biotech Inc (MBRX.OQ)

MBRX.OQ on NASDAQ Stock Exchange Capital Market

1.65USD
26 Sep 2018
Change (% chg)

$0.04 (+2.48%)
Prev Close
$1.61
Open
$1.65
Day's High
$1.65
Day's Low
$1.65
Volume
3,212
Avg. Vol
31,676
52-wk High
$3.33
52-wk Low
$1.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.198
Mar '18 0.00 -0.083
FY 2017 Dec '17 0.00 -0.150
Sep '17 0.00 -0.140
Jun '17 0.00 -0.192
Mar '17 0.00 -0.023
FY 2016 Dec '16 0.00 -0.311
Sep '16 0.00 -0.124
Jun '16 0.00 -0.088
Mar '16 0.00 -0.023
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.67 32.94
P/E High - Last 5 Yrs. -- 41.98 47.16
P/E Low - Last 5 Yrs. -- 23.66 24.91
Beta -- 0.90 0.87
Price to Sales (TTM) -- 4.39 6.45
Price to Book (MRQ) 2.58 3.66 4.03
Price to Tangible Book (MRQ) 7.72 5.17 6.04
Price to Cash Flow (TTM) -- 21.70 22.86
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.79 1.66
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.87 -6.01
Payout Ratio(TTM) -- 49.49 46.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.58 8.30
Sales (TTM) vs TTM 1 Yr. Ago -- 4.58 6.68
Sales - 5 Yr. Growth Rate -- 6.93 7.55
EPS (MRQ) vs Qtr. 1 Yr. Ago -3.28 18.26 25.27
EPS (TTM) vs TTM 1 Yr. Ago 12.17 -- --
EPS - 5 Yr. Growth Rate -- 6.49 7.61
Capital Spending - 5 Yr. Growth Rate -- 7.83 8.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.21
Current Ratio (MRQ) 3.13 2.95 2.99
LT Debt to Equity (MRQ) 0.00 8.84 11.08
Total Debt to Equity (MRQ) 0.00 11.11 13.87
Interest Coverage (TTM) -5.36 40.66 34.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.00 54.59
Gross Margin - 5 Yr. Avg. -- 53.22 53.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.68 15.94
Operating Margin (TTM) -- 13.37 3.99
Operating Margin - 5 Yr. Avg. -- 14.31 11.11
Pre-Tax Margin (TTM) -- 13.76 4.33
Pre-Tax Margin - 5 Yr. Avg. -- 14.62 11.30
Net Profit Margin (TTM) -- 10.35 1.03
Net Profit Margin - 5 Yr. Avg. -- 10.90 7.63
Effective Tax Rate (TTM) -- 20.66 20.61
Effective Tax Rate - 5 Yr. Avg. -- 23.90 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 836,081,625 730,158,786
Net Income/Employee (TTM) -- 96,835,004 84,453,268
Receivable Turnover (TTM) -- 5.04 5.05
Inventory Turnover (TTM) -- 2.54 3.63
Asset Turnover (TTM) 0.00 0.84 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -57.83 10.13 9.86
Return on Assets - 5 Yr. Avg. -- 11.48 11.00
Return on Investment (TTM) -66.57 13.17 12.84
Return on Investment - 5 Yr. Avg. -- 14.81 14.14
Return on Equity (TTM) -72.76 15.10 14.95
Return on Equity - 5 Yr. Avg. -- 16.00 15.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -32.16 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Moleculin Biotech Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.17 -4.76 82 76
13 Week -8.52 -14.56 61 72
26 Week -13.44 -22.43 63 55
52 Week -33.20 -42.79 35 36
YTD -13.44 -20.62 86 42
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.38%
# of Holders: 23
Total Shares Held: 2,789,073
3 Mo. Net Change: 255,281
# New Positions: 4
# Closed Positions: 4
# Increased Positions: 11
# Reduced Positions: 4
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.